Possible new NextCure shares
NXTCDilution
Known so far: no new shares from the prospectus covers read · shelf room about $4.2M · not yet read: warrants, converts, options, ATM.
Shelf room
- Room today about $4.2M, maybe lower
- One third of float $4.2M ($12.6M float, Jun 30, 2025)
- Sold off it, 12 months nothing
How this is worked out
Shelf room about $4.2M on the S-3 of Nov 26, 2025: the baby-shelf rule (public float under $75M) caps sales at one third of the $12.6M public float stated as of Jun 30, 2025, $4.2M, nothing sold off it in the last 12 months; 1 more sale off the shelf with no size read, so the room may be lower. Sources: S-3 Nov 26, 2025, effective Dec 11, 2025 · public float, as of Jun 30, 2025 · 424B1 Dec 11, 2025.
What could become new NextCure (NXTC) shares, from its 10-Q, 10-K, S-3 or 424B filings.
Read so far: the cover share count (4.6M shares, +71% from 2.7M on Aug 4, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.
Shares outstanding
4.6M
Nov 2024 to Jul 2026: from 2.3M to 4.6M. Adjusted for the 1-for-12 reverse split by Aug 4, 2025: each earlier count is divided by the ratio of every split after it.
From the share count on the cover of each 10-Q and 10-K, dated as each cover states.
Follow NextCure
New shelves, offerings, 10-Qs and 10-Ks from NXTC, explained in plain English when they reach EDGAR.
Watch NXTC in the app